GAS UPTAKE STUDIES OF DEUTERIUM-ISOTOPE EFFECTS ON DICHLOROMETHANE METABOLISM IN FEMALE B6C3F1 MICE IN-VIVO

被引:36
|
作者
ANDERSEN, ME
CLEWELL, HJ
MAHLE, DA
GEARHART, JM
机构
[1] ICF KE,DIV KS GRP,RUSTON,LA 71270
[2] MANTECH ENVIRONM TECHNOL INC,DAYTON,OH 45437
关键词
D O I
10.1006/taap.1994.1193
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In common with a diverse group of low-molecular-weight volatile substrates, dichloromethane (DCM; methylene chloride) is a high-affinity, low-capacity substrate for oxidation by several cytochrome P450 isoenzymes in vivo. DCM oxidation, catalyzed primarily by the 2E1 and 2B1 cytochrome P450 isoforms, yields carbon monoxide (CO) and carbon dioxide. We have studied the characteristics of DCM oxidation in vivo by examining the metabolism of DCM and of both deuterated forms ([H-2(2)]DCM and [H-2]DCM) in female B6C3F1 mice with gas uptake methods. Gas uptake and CO production curves were analyzed by physiologically based pharmacokinetic (PBPK) modeling techniques, permitting differentiation of isotope effects on specific metabolic parameters from those associated with blood flow or diffusion limitations in vivo. A marked isotope effect was observed on the moles of CO produced per mole of DCM oxidized (0.76 +/- 0.06, 0.33 +/- 0.006, and 0.31 +/- 0.07, with DCM, [H-2]DCM, and [H-2(2)]DCM, respectively). Based on these ratios, the calculated k(H)/k(D) ratio for the rate constant of disproportionation of the putative formyl chloride intermediate was about 7, indicating a significant role of C-H bond breaking in this reaction. Deuterium substitution altered the apparent K-m for metabolism; there was 14-fold increase in the apparent K-m between DCM and [H-2(2)]DCM (6.5 +/- 0.69 to 97 +/- 3.5 mu M) with little effect on K-m with [H-2]DCM (14.4 +/- 0.015 mu M). V-max was not greatly affected by deuteration (151 +/- 1.2, 116 +/- 0.82, and 149 +/- 2.3 mu mol/hr/kg with DCM, [H-2]DCM, and [H-2(2)]DCM, respectively). Two kinetic mechanisms are discussed, both of which are consistent with these observations. One, a conventional cytochrome P450 mechanism has a rate-limiting product-release step after the isotopically sensitive step; a second, more like a peroxidase mechanism, has a flux-limiting oxygen activation step followed by a second-order reaction between an activated oxygen-enzyme complex and DCM. Regardless of the correct mechanism, the in vivo kinetic constants for oxidation of DCM are complex and represent more than simple rate-limiting bond-breaking (V-max) and enzyme-substrate binding (K-m). Current PBPK models for metabolism of these volatiles may have to be restructured to account for this unusual kinetic mechanism. (C) 1994 Academic Press, Inc.
引用
收藏
页码:158 / 165
页数:8
相关论文
共 50 条
  • [41] Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice
    Abbas, RR
    Seckel, CS
    Kidney, JK
    Fisher, JW
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (12) : 1340 - 1346
  • [42] METABOLISM AND ELIMINATION OF OXAZEPAM IN B6C3F1 AND SWISS-WEBSTER MICE
    GRIFFIN, RJ
    BURKA, LT
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (05) : 918 - 926
  • [43] Absorption and metabolism of triclosan after application to the skin of B6C3F1 mice
    Fang, Jia-Long
    Vanlandingham, Michelle
    da Costa, Goncalo Gamboa
    Beland, Frederick A.
    ENVIRONMENTAL TOXICOLOGY, 2016, 31 (05) : 609 - 623
  • [44] ROLE OF METABOLISM IN COCAINE-INDUCED IMMUNOSUPPRESSION IN SPLENOCYTE CULTURES FROM B6C3F1 FEMALE MICE
    JEONG, TC
    MATULKA, RA
    JORDAN, SD
    YANG, KH
    HOLSAPPLE, MP
    IMMUNOPHARMACOLOGY, 1995, 29 (01): : 37 - 46
  • [45] IMMUNOTOXIC EFFECTS OF SUBCUTANEOUSLY ADMINISTERED DIMETHYLBENZANTHRACENE ON B6C3F1 MICE
    WARD, EC
    MURRAY, MJ
    LAUER, LD
    DEAN, JH
    FEDERATION PROCEEDINGS, 1983, 42 (03) : 353 - 353
  • [46] THE PHARMACOKINETICS OF DICHLOROMETHANE .1. DISPOSITION IN B6C3F1 MICE FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION
    ANGELO, MJ
    PRITCHARD, AB
    HAWKINS, DR
    WALLER, AR
    ROBERTS, A
    FOOD AND CHEMICAL TOXICOLOGY, 1986, 24 (09) : 965 - 974
  • [47] STYRENE INHALATION TOXICITY STUDIES IN MICE .1. HEPATOTOXICITY IN B6C3F1 MICE
    MORGAN, DL
    MAHLER, JF
    OCONNOR, RW
    PRICE, HC
    ADKINS, B
    FUNDAMENTAL AND APPLIED TOXICOLOGY, 1993, 20 (03): : 325 - 335
  • [48] Immunomodulatory effects of black cohosh (Actaea racemosa) extract in female B6C3F1/N mice
    Smith, Matthew J.
    Germolec, Dori R.
    Frawley, Rachel P.
    White, Kimber L., Jr.
    TOXICOLOGY, 2013, 308 : 146 - 157
  • [49] DISPOSITION OF INHALED ISOPRENE IN B6C3F1 MICE
    BOND, JA
    BECHTOLD, WE
    BIRNBAUM, LS
    DAHL, AR
    MEDINSKY, MA
    SUN, JD
    HENDERSON, RF
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 107 (03) : 494 - 503
  • [50] Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice
    Doerge, DR
    Young, JF
    McDaniel, LP
    Twaddle, NC
    Churchwell, MI
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 202 (03) : 258 - 267